Harpoon Therapeutics, Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$31.9M

Net Income/Loss (FY2022)

-$67.7M

Total Assets (FY2022)

$73.7M

Total Equity (FY2022)

$5.4M

Cash Flows from Operating Activities (FY2022)

-$89.2M

Source: Harpoon Therapeutics, Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.